Publication date: Available online 26 December 2018
Source: Trends in Endocrinology & Metabolism
Author(s): Aline Loehfelm, Alisa Boucsein, Dominik Pretz, Alexander Tups
Metabolic syndrome and Alzheimer's disease (AD) are two major health issues in modern society causing an extraordinary financial burden for the global healthcare systems. A tight link between the pathologies of obesity and type 2 diabetes (T2D), and more recently between T2D and AD, has been discovered. Furthermore, in recent years it has become apparent that the circadian clock has an important function in controlling metabolism. This review integrates the role of the circadian clock in the development of these metabolic derangements and vice versa. Common features such as central insulin resistance, altered glycogen synthase kinase 3β (GSK3β) signalling, and central inflammation are discussed, and therapeutic interventions targeting those mechanisms are mentioned briefly.
http://bit.ly/2ERWDYQ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου